ASHLEY VAZEEN: Open Payments
NPI 1952785701 · CARSON CITY, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,582 in 78 payments from 17 companies in 2025. Trend: 2023 $1,707 · 2024 $2,218 · 2025 $1,582
Food & beverage: $1,506Education: $76
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $434 |
| Janssen Biotech, Inc. | 16 | $278 |
| UCB, Inc. | 5 | $115 |
| Lilly USA, LLC | 7 | $114 |
| Regeneron Healthcare Solutions, Inc. | 4 | $102 |
| Incyte Corporation | 4 | $99 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $71 |
| Galderma Laboratories, L.P. | 3 | $62 |
| E.R. Squibb & Sons, L.L.C. | 2 | $55 |
| Biofrontera Inc. | 3 | $54 |
Products named: TREMFYA, BOTOX, DUPIXENT, Bimzelx, TALTZ, RINVOQ, OPZELURA, SKYRIZI.
Industry payments across NV — which companies pay providers there.
